Revelation Biosciences Inc [NASDAQ: REVB] surged by $0.0 during the normal trading session on while it closed the day at $0.75.
Revelation Biosciences Inc stock has also loss -0.50% of its value over the past 7 days. However, REVB stock has declined by -25.25% in the 3 months of the year. Over the past six months meanwhile, it has lost -54.24% and lost -94.97% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for REVB stock reached $3.24 million, with 4.29 million shares outstanding and 4.29 million shares in the current float. Compared to the average trading volume of 541.74K shares, REVB reached a trading volume of 130568 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Revelation Biosciences Inc [REVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for REVB shares is $12.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on REVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Revelation Biosciences Inc is set at 0.06 The Price to Book ratio for the last quarter was 1.21, with the Price to Cash per share for the same quarter was set at 1.52.
REVB stock trade performance evaluation
Revelation Biosciences Inc [REVB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.50. With this latest performance, REVB shares dropped by -9.27% in over the last four-week period, additionally sinking by -54.24% over the last 6 months – not to mention a drop of -96.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for REVB stock in for the last two-week period is set at 41.28, with the RSI for the last a single of trading hit 38.53, and the three-weeks RSI is set at 42.66 for Revelation Biosciences Inc [REVB]. The present Moving Average for the last 50 days of trading for this stock 0.8290, while it was recorded at 0.7506 for the last single week of trading, and 1.7070 for the last 200 days.
Revelation Biosciences Inc [REVB]: An insightful look at the core fundamentals
Revelation Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.64 and a Current Ratio set at 1.64.
Revelation Biosciences Inc [REVB]: Institutional Ownership
There are presently around $2.31%, or 2.31%% of REVB stock, in the hands of institutional investors.
